`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`BLUEBIRD BIO, INC.,
`Petitioner,
`
`v.
`
`SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH,
`Patent Owner.
`____________
`IPR2023-00074 (Patent 8,058,061)
`____________
`
`
`
`
`JOINT STIPULATION TO MODIFY DUE DATES 1, 2, AND 3
`
`
`
`
`
`
`IPR2023-00074 (Patent 8,058,061)
`
`
`
`
`
`
`
`On April 24, 2023, the Patent Trial and Appeal Board (PTAB) issued a
`
`Scheduling Order (e.g., IPR2023-00074, Paper 9) in the above captioned inter
`
`partes review (IPR) cases, setting forth due dates for the parties to take action in
`
`this trial. The Scheduling Order states that the parties may stipulate to different
`
`dates for DUE DATES 1, 5, and 6, as well as the portion of DUE DATE 2 related
`
`to Petitioner’s reply (earlier or later, but no later than DUE DATE 3 for Patent
`
`Owner’s sur-reply) and the portion of DUE DATE 3 related to Patent Owner’s sur-
`
`reply (earlier or later, but no later than DUE DATE 7). (Id. at 8.)
`
`As permitted by the PTAB in the Scheduling Order, Patent Owner and
`
`Petitioner hereby stipulate to modify DUE DATES 1-3 as follows:
`
`EVENT
`
`DATE FROM
`SCHEDULING ORDER
`
`DATE PURSUANT TO
`THIS STIPULATION
`
`DUE DATE 1
`
`July 18, 2023
`
`August 1, 2023
`
`DUE DATE 2
`(Petitioner’s reply):
`DUE DATE 3
`(Patent Owner’s sur-reply) November 21, 2023
`
`October 10, 2023
`
`October 24, 2023
`
`December 5, 2023
`
`This stipulation does not affect or otherwise modify any other DUE DATES
`
`set in the Scheduling Order.
`
`This paper is being filed on behalf of Patent Owner with the approval of
`
`counsel for the Petitioner.
`
`
`
`
`
`-2-
`
`
`
`
`
`IPR2023-00074 (Patent 8,058,061)
`
`
`
`
`
`
`
`Respectfully submitted,
`
`Dated: June 2, 2023
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`By: /s/ Luke Toft
`Luke Toft (Reg. No. 75,311)
`FOX ROTHSCHILD LLP
`33 South Sixth Street, Suite 3600
`Minneapolis, MN 55402
`Telephone: (612) 607-7000
`Facsimile: (612) 607-7100
`ltoft@foxrothschild.com
`
`Joe Chen, Ph.D. (Reg. No. 70,066)
`FOX ROTHSCHILD LLP
`997 Lenox Drive
`Lawrenceville, NJ 08648
`Telephone: (609) 844-3024
`Facsimile: (609) 896-1469
`joechen@foxrothschild.com
`
`Attorneys for San Rocco Therapeutics,
`LLC, Responding on Behalf of Patent
`Owner Sloan Kettering Institute for
`Cancer Research
`
`
`
`-3-
`
`
`
`
`
`IPR2023-00074 (Patent 8,058,061)
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`Pursuant to 37 CFR § 42.6(e), the undersigned hereby certifies that on June 2,
`
`2023, the foregoing Joint Stipulation to Modify Due Dates 1, 2, and 3, was served
`
`via e-mail, as authorized by the Petitioner, at the following email correspondence
`
`address of record:
`
`Naveen Modi
`Daniel Zeilberger
`PAUL HASTINGS LLP
`2050 M Street NW
`Washington, D.C. 20036
`bluebird-IPR-PH@paulhastings.com
`
`Eric W. Dittmann
`Max H. Yusem
`Krystina L. Ho
`PAUL HASTINGS LLP
`200 Park Avenue
`New York, NY 10166
`bluebird-IPR-PH@paulhastings.com
`
`
`
`
`Dated: June 2, 2023
`
`
`
`
`
`/s/ Luke Toft
`Luke Toft (Reg. No. 75,311)
`Counsel for San Rocco Therapeutics, LLC,
`Responding on Behalf of Patent Owner
`
`
`
`
`-4-
`
`
`
`
`
`
`
`
`
`
`
`
`